Outcomes of a 5-year follow-up of patients with sessile serrated adenomas.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 22229626)

Published in Scand J Gastroenterol on January 10, 2012

Authors

Anouar Teriaky1, David K Driman, Nilesh Chande

Author Affiliations

1: Department of Medicine, The University of Western Ontario and London Health Sciences Centre, London, Ontario, Canada. ateriaky@uwo.ca

Articles citing this

Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22

Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. J Gastroenterol (2012) 1.18

Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol (2015) 1.00

Serrated pathway: alternative route to colorectal cancer. World J Gastroenterol (2013) 0.99

Risk factors for serrated polyps of the colorectum. Dig Dis Sci (2014) 0.96

Colorectal cancer screening and surveillance in the elderly: updates and controversies. Gut Liver (2015) 0.81

Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics. Virchows Arch (2014) 0.79

The effect of polyp location and patient gender on the presence of dysplasia in colonic polyps. Clin Transl Gastroenterol (2012) 0.79

Characteristics and outcomes of endoscopically resected colorectal cancers that arose from sessile serrated adenomas and traditional serrated adenomas. Intest Res (2016) 0.77

Histology subtypes and polyp size are associated with synchronous colorectal carcinoma of colorectal serrated polyps: a study of 499 serrated polyps. Am J Cancer Res (2014) 0.77

British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut (2017) 0.76

Snaring large serrated polyps. Surg Endosc (2012) 0.75

Sessile serrated adenoma/polyps: Where are we at in 2016? World J Gastroenterol (2016) 0.75

Ubiquitin ligase A20 regulates p53 protein in human colon epithelial cells. J Biomed Sci (2013) 0.75

What influences preneoplastic colorectal lesion recurrence? Oncotarget (2016) 0.75

Colorectal cancer anatomic distribution patterns remain the same after sessile serrated adenoma/polyp considered cancer precursor: a 9-year comparison study from community-based endoscopy centers. J Gastrointest Oncol (2016) 0.75

The clinical impact of serrated colorectal polyps. Clin Epidemiol (2017) 0.75

Risk of Metachronous Advanced Neoplastic Lesions in Patients with Sporadic Sessile Serrated Adenomas Undergoing Colonoscopic Surveillance. Am J Gastroenterol (2016) 0.75

Articles by these authors

Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol (2008) 2.30

Oral metastatic hepatocellular carcinoma: a changing demographic in Europe and North America. Immunohistochemical advances in the microscopic diagnosis. Oral Oncol (2010) 2.08

Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol (2006) 1.89

Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. Can J Gastroenterol (2006) 1.62

Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol (2007) 1.43

Ectopic breast tissue presenting as an anal polyp. Can J Surg (2007) 1.42

Current practice patterns among pathologists in the assessment of venous invasion in colorectal cancer. J Clin Pathol (2011) 1.33

Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl (2007) 1.27

Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol (2008) 1.23

The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment. J Clin Pathol (2006) 1.17

Gastrointestinal stromal tumors: a contemporary review. Pathol Res Pract (2006) 1.11

Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome. Hum Pathol (2012) 1.04

Microscopic colitis: an update. J Clin Gastroenterol (2009) 1.04

Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentation. Scand J Gastroenterol (2005) 1.02

The human proton-coupled folate transporter (hPCFT): modulation of intestinal expression and function by drugs. Am J Physiol Gastrointest Liver Physiol (2009) 0.95

Guideline for optimization of colorectal cancer surgery and pathology. J Surg Oncol (2010) 0.95

A cross-sectional study of the association between overnight call and irritable bowel syndrome in medical students. Can J Gastroenterol (2012) 0.95

A survey of digital rectal examination training in Canadian medical schools. Can J Gastroenterol (2012) 0.95

Venous invasion in colorectal cancer: impact of an elastin stain on detection and interobserver agreement among gastrointestinal and nongastrointestinal pathologists. Am J Surg Pathol (2013) 0.92

Is Helicobacter pylori being treated appropriately? A study of inpatients and outpatients in a tertiary care centre. Can J Gastroenterol (2007) 0.91

Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma. Am J Surg Pathol (2015) 0.91

Recombinant human erythropoietin improves gut barrier function in a hemorrhagic shock and resuscitation rat model. J Trauma (2011) 0.90

Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation. Biochem Pharmacol (2012) 0.88

Expression of human telomerase reverse transcriptase, Survivin, DD3 and PCGEM1 messenger RNA in archival prostate carcinoma tissue. Can J Urol (2006) 0.88

Sargramostim (GM-CSF) for induction of remission in Crohn's disease: a cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials. Inflamm Bowel Dis (2012) 0.88

Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis. Mol Carcinog (2002) 0.88

Microscopic colitis associated with lansoprazole: report of two cases and a review of the literature. Scand J Gastroenterol (2007) 0.88

Percutaneous endoscopic gastrostomy tube placement for end-stage palliation of malignant gastrointestinal obstructions. Saudi J Gastroenterol (2012) 0.87

Pathological grading of regression: an International Study Group perspective. J Clin Pathol (2012) 0.87

Are there any differences in the efficacy and safety of different formulations of Oral 5-ASA used for induction and maintenance of remission in ulcerative colitis? evidence from cochrane reviews. Inflamm Bowel Dis (2013) 0.87

Methotrexate for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2009) 0.87

The Next Wave of Biological Agents for the Treatment of IBD: Evidence from Cochrane Reviews. Inflamm Bowel Dis (2016) 0.86

Survivin and hedgehog protein expression in serrated colorectal polyps: an immunohistochemical study. Hum Pathol (2007) 0.86

Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada -- an epidemiological study from 1964-2002. Can J Gastroenterol (2006) 0.85

Methotrexate for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2014) 0.84

Predictors of disease severity in ulcerative colitis patients from Southwestern Ontario. World J Gastroenterol (2010) 0.83

Sleep disruption secondary to overnight call shifts is associated with irritable bowel syndrome in residents: a cross-sectional study. Am J Gastroenterol (2012) 0.81

Sargramostim (GM-CSF) for induction of remission in Crohn's disease. Cochrane Database Syst Rev (2011) 0.81

Pathological reporting of colorectal cancer specimens: a retrospective survey in an academic Canadian pathology department. Can J Surg (2008) 0.80

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev (2016) 0.80

Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices. Inflamm Bowel Dis (2014) 0.79

Quality of Internet-based information on gastrointestinal diseases. Can J Gastroenterol (2011) 0.79

The safety and efficacy of adalimumab in patients with Crohn's disease: the experience of a single Canadian tertiary care centre. Scand J Gastroenterol (2013) 0.79

Opioid use is associated with decreased quality of life in patients with Crohn's disease. Saudi J Gastroenterol (2014) 0.78

Transcutaneous bowel sonography for inflammatory bowel disease is sensitive and specific when performed in a nonexpert low-volume North American center. J Ultrasound Med (2013) 0.78

Wait times for diagnostic colonoscopy among outpatients with colorectal cancer: a comparison with Canadian Association of Gastroenterology targets. Can J Gastroenterol (2012) 0.78

Lobular capillary hemangioma of the liver. Hepatobiliary Pancreat Dis Int (2009) 0.78

Tumor necrosis factor-alpha antagonists twenty years later: what do Cochrane reviews tell us? Inflamm Bowel Dis (2014) 0.77

Venous invasion in oesophageal adenocarcinoma: enhanced detection using elastic stain and association with adverse histological features and clinical outcomes. Histopathology (2013) 0.77

Interobserver variability in assessing dysplasia and architecture in colorectal adenomas: a multicentre Canadian study. J Clin Pathol (2014) 0.76

Low dose naltrexone for induction of remission in Crohn's disease. Cochrane Database Syst Rev (2014) 0.76

The management of eosinophilic esophagitis in adults. J Clin Gastroenterol (2013) 0.76

Ischemic pancolitis: recognizing a rare form of acute ischemic colitis. Can J Surg (2004) 0.75

Colorectal cancer in a 9-year-old due to combined EPCAM and MSH2 germline mutations: case report of a unique genotype and immunophenotype. J Clin Pathol (2013) 0.75

Venous thromboprophylaxis in gastrointestinal bleeding. Can J Gastroenterol Hepatol (2015) 0.75

Use of budesonide in the treatment of microscopic colitis. Saudi J Gastroenterol (2010) 0.75

Evaluating necrosis and chemotherapy response in colorectal cancer liver metastases. Comment on Knijn et al. (2013). Histopathology (2013) 0.75

Severe hypernatremic dehydration and metabolic acidosis due to neonatal intestinal microvillus inclusion disease. Neonatology (2011) 0.75

Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study. Saudi J Gastroenterol (2015) 0.75

Nonutility of routine testing of stool for ova and parasites in a tertiary care Canadian centre. Can J Microbiol (2012) 0.75

Latent lymphocytic enterocolitis associated with celiac disease manifesting after resection for colon cancer: case report and review of the literature. Can J Gastroenterol (2008) 0.75

A treatable mimicker of cholangiocarcinoma. Can J Gastroenterol Hepatol (2015) 0.75

A middle-aged woman with a persistent gastrointestinal bleed. Saudi J Gastroenterol (2011) 0.75

Introduction to Cochrane systematic reviews. Inflamm Bowel Dis (2011) 0.75

Pathologic quiz case: a man with an asymptomatic left testicular mass. Arch Pathol Lab Med (2003) 0.75

Use of internet resources by patients awaiting gastroenterology consultation. Turk J Gastroenterol (2015) 0.75

Authors' response - the prognostic benefits of routine staining with elastica to increase detection of venous invasion in colorectal cancer specimens. J Clin Pathol (2011) 0.75

Anti-tuberculous therapy for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2016) 0.75

Treatment of an initial infection with clostridium difficile in patients with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.75

Interventions for treating collagenous colitis. Cochrane Database Syst Rev (2017) 0.75